Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-85.54	37.15	256.84
Graham Fair Price	-52.82	275.08	583.08
PEG	9220.93	-0.11	< 0.005
Price/Book	0.40	0.80	0.79
Price/Cash Flow	-872.38	-26.71	-2.75
Prices/Earnings	385.28	8.77	1.81
Price/Sales	90.13	17.33	9.11
Price/FCF	-872.38	-26.71	-2.75
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.93	0.98	1.00
Operating Margin	2840.39	0.61	-0.02
ROA	-79.27	< 0.005	0.03
ROE	0.11	0.02	-79.31
ROIC	< 0.005	0.02	824.03
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.00	100.00
Dividends QOQ	0.04	0.02	-46.82
EBIT QOQ	0.90	16.80	1770.91
EPS QOQ	15.32	-0.80	-94.79
FCF QOQ	-10.93	0.89	-91.81
Revenue QOQ	1.59	-0.46	-70.93
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-130338.00	-100.00
Days Sales Outstanding (DSO)	224.07	396.83	77.11
Inventory Turnover	0.00	< 0.005	-100.00
Debt/Capitalization	0.25	0.25	-1.26
Quick Ratio	0.21	62.48	29121.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	370.89	384.67	3.71
Cash	83.56	378.59	353.08
Capex	0.00	0.00	0.00
Free Cash Flow	-107.15	-11.47	89.29
Revenue	32.30	17.69	-45.23
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.13	7.84	5922.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.67	8.75	-81.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating